Defective N-glycosylation in tumor-infiltrating CD8+ T cells impairs IFN-γ-mediated effector function

Immunol Cell Biol. 2023 Aug;101(7):610-624. doi: 10.1111/imcb.12647. Epub 2023 Apr 28.

Abstract

T cell-mediated antitumor immunity is modulated, in part, by N-glycosylation. However, the interplay between N-glycosylation and the loss of effector function in exhausted T cells has not yet been fully investigated. Here, we delineated the impact of N-glycosylation on the exhaustion of tumor-infiltrating lymphocytes in a murine colon adenocarcinoma model, focusing on the IFN-γ-mediated immune response. We found that exhausted CD8+ T cells downregulated the oligosaccharyltransferase complex, which is indispensable for N-glycan transfer. Concordant N-glycosylation deficiency in tumor-infiltrating lymphocytes leads to loss of antitumor immunity. Complementing the oligosaccharyltransferase complex restored IFN-γ production and alleviated CD8+ T cell exhaustion, resulting in reduced tumor growth. Thus, aberrant glycosylation induced in the tumor microenvironment incapacitates effector CD8+ T cells. Our findings provide insights into CD8+ T cell exhaustion by incorporating N-glycosylation to understand the characteristic loss of IFN-γ, opening new opportunities to amend the glycosylation status in cancer immunotherapies.

Keywords: IFN-γ; N-glycosylation; T cell exhaustion; tumor immunology; tumor-infiltrating lymphocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma*
  • Animals
  • CD8-Positive T-Lymphocytes
  • Colonic Neoplasms*
  • Glycosylation
  • Humans
  • Interferon-gamma / metabolism
  • Lymphocytes, Tumor-Infiltrating
  • Mice
  • Tumor Microenvironment

Substances

  • Interferon-gamma